High-Throughput Biopharmaceutical Drug Development: Meeting the Coming Challenge
Publication
Article
BioPharm InternationalBioPharm International-02-01-2002
Volume 15
Issue 2
Pages: 20-28
By Rajiv Nayar and Mark C. Manning, HTD Biosystms, Inc., pp. 20-28. Outsourcing is often considered a way to expedite drug development, but other options exist for companies that don't choose it yy} or that run up against the capacity shortage. The resources devoted to speeding up the drug discovery process led to combinatorial libraries, high-throughput screening, proteomics, and genomics. Now the same types of innovation can be applied to drug development to prevent valuable lead compounds from sitting idle on the shelf.
Articles in this issue
Using a Model and Tools to Standardize the Preparation for a Preapproval Inspection
Sale of Your Product Can Prevent Patenting: How to Avoid the On-Sale Bar
Outsourcing Outlook: Reaping the Benefits of E-Procurement
The Immunogenicity of Therapeutic Proteins
Analytical Advances: Calibration Management of Outsourced Calibrations
High-Throughput Biopharmaceutical Drug Development: Meeting the Coming Challenge
Inside Washington: Costs and Controls Challenge Manufacturers
21 CFR Part 11: (Un)Expected Added Value
Recent Videos
Related Content
